Rychlé odkazy
Kategorie
Odběr a výroba plazmy
Learn more about plasma collection and discover certified plasma centers near you.
Časopis The Source
Subscribe to the international magazine of the plasma protein therapeutics industry.
Informační listy
Fact sheets provide additional information about the global plasma protein therapeutics industry.
Často kladené otázky o plazmě
Get answers about plasma therapies and the processes surrounding donation and collection procedures.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Apr 28, 2009
Statement on the Safety of Plasma Protein Therapies and Swine Influenza Virus
PPTA member companies are committed to providing safe and effective therapies and PPTA understands that patients who rely on these often life-saving therapies may have concerns about the possible transmission of Swine Influenza Virus through them in view of the recent outbreak in humans. Therapies produced by PPTA members remain safe and available.
All
PPTA statements
Apr 28, 2009
Statement on the Safety of Plasma Protein Therapies and Swine Influenza Virus
PPTA member companies are committed to providing safe and effective therapies and PPTA understands that patients who rely on these often life-saving therapies may have concerns about the possible transmission of Swine Influenza Virus through them in view of the recent outbreak in humans. Therapies produced by PPTA members remain safe and available.
All
PPTA statements
Jun 1, 2007
PPTA Statement on Safety of Plasma Protein Therapies and the H5N1 Viruses
PPTA members are committed to providing safe and effective therapies and PPTA understands that patients who rely on plasma protein therapies may have concerns about the possible transmission of highly virulent strains of influenza H5N1 viruses through these therapies. Therefore, PPTA members continue to work to ensure that these viruses or any other emerging disease, do not compromise the safety of plasma protein therapies.
All
PPTA statements
Jun 1, 2007
PPTA Statement on Safety of Plasma Protein Therapies and the H5N1 Viruses
PPTA members are committed to providing safe and effective therapies and PPTA understands that patients who rely on plasma protein therapies may have concerns about the possible transmission of highly virulent strains of influenza H5N1 viruses through these therapies. Therefore, PPTA members continue to work to ensure that these viruses or any other emerging disease, do not compromise the safety of plasma protein therapies.
All
PPTA statements
Jul 21, 2005
Statement on Update on Safety of Albumin
The Plasma Protein Therapeutics Association (PPTA) appreciates actions taken by the FDA and the Blood Products Advisory Committee (BPAC) with respect to the safety of albumin.
All
PPTA statements
Jul 21, 2005
Statement on Update on Safety of Albumin
The Plasma Protein Therapeutics Association (PPTA) appreciates actions taken by the FDA and the Blood Products Advisory Committee (BPAC) with respect to the safety of albumin.
All
PPTA statements
Oct 21, 2004
PPTA Statement on Review of Donor Weight Loss Monitoring
The Plasma Protein Therapeutics Association (PPTA) is the international trade association and standards-setting organization for the world's major producers of plasma-derived and recombinant analog therapies.
All
PPTA statements
Oct 21, 2004
PPTA Statement on Review of Donor Weight Loss Monitoring
The Plasma Protein Therapeutics Association (PPTA) is the international trade association and standards-setting organization for the world's major producers of plasma-derived and recombinant analog therapies.
All
PPTA statements
No results found